• SalvaRx Group

    The SalvaRx Group is a drug development company focused on cancer immunotherapy
  • Cancer Immunotherapy

    Cancer immunotherapy—treatments that harness and enhance the innate powers of the immune system to fight cancer—is one of the most promising cancer treatment modalities since the development of targeted therapies.

About Cancer Immunotherapy

Cancer is the leading cause of death world-wide and is characterized by the uncontrolled growth of abnormal cells whose ability to evade the human body’s immune system is a significant factor in their proliferation and persistence.

Read more

About iOx Therapeutics

Founded in February 2015 by Professor Cerundolo, iOx Therapeutics is a spin-out from the University of Oxford started to commercialise discoveries made as part of a long-running collaboration between Oxford and the Ludwig Institute for Cancer Research.

Read more

SalvaRx Corporate Strategy and History

The SalvaRx Group is a drug discovery and development company focused on immune-oncology; SalvaRx invests in novel cancer immunotherapies.

Read more